SINOMED(R) Completes One-Year Follow-Up of the PIONEER-III Eur...
TIANJIN, China, July 13, 2020 /PRNewswire-AsiaNet/-- SINOMED, a developer of innovative neuro- and cardiovascular technologies, announced the completion of the 1-year follow-up in the PIONEER-III, randomized global trial evaluating the BuMA Supreme Drug-Eluting Coronary Stent (DES). Once completed, ...
Authors: LATEST ASIANET NEWS RELEASES